Abstract: The present invention relates to compounds of general formula (I) ##STR1## and physiologically acceptable salts thereof wherein the group NR.sub.1 R.sub.2 represents a 5-7 membered saturated heterocyclic ring which may be substituted by one or two methyl groups; R.sub.3 is C.sub.1-6 alkyl, C.sub.3-6 cycloalkyl or phenyl optionally substituted by 1 or 2 halogen atoms; R.sub.4 is phenyl or phenyl substituted by one or two groups selected from the group consisting of halogen, C.sub.1-4 alkyl, trifluoromethyl, trifluoromethoxy or (CH.sub.2).sub.n R.sub.5 wherein n is zero or 1 and R.sub.5 represents C.sub.1-4 alkoxy, hydroxy, nitro, cyano, CO.sub.2 R.sub.6, S(O).sub.p CH.sub.3, NR.sub.7 R.sub.8, CONR.sub.7 R.sub.8, SO.sub.2 NR.sub.7 CO(C.sub.1-4)alkyl, tetrazolyl, carboxamidotetrazolyl, or a 3-trifluoromethyl 1,2,4-triazolyl; R.sub.6 is hydrogen, C.sub.1-4 alkyl or benzyl; R.sub.7 is hydrogen or C.sub.1-4 alkyl, R.sub.8 is hydrogen, C.sub.1-4 alkyl, SO.sub.2 CH.sub.3 or SO.sub.2 CF.sub.3, X represent hydrogen, C.

Abstract: Amide derivatives of formula (I) and their pharmaceutically acceptable salts (where a and b each represent 0, 1, 2 or 3 such that a+b=0, 1, 2 or 3, the dotted line represents an optional double bond, A is an optionally substituted C.sub.1-2 -alkylene chain, R is mono or bicyclic aryl or heteroaryl radical, R.sup.1 is hydrogen or lower alkyl, R.sup.2 is an aryl, aralkyl, heteroaryl or heteroarylalkyl and --CONR.sup.3 R.sup.4 represents a specified amide group) are 5-HT.sub.1A binding agents and may be used, for example, as anxiolytics.

Abstract: Triphendioxazine compounds corresponding to the formula (1) ##STR1## in which Z is a radical of the formula (2) ##STR2## in which Y.sup.1 and Y.sup.2 each vinyl .beta.-hydroxyethyl or an ethyl radical which contains a substituent which can be eliminated under alkaline conditions in the .beta.-position, and in which Y.sup.1 and Y.sup.2 are not simultaneously .beta.-hydroxyethyl, W.sup.1 and W.sup.2 are both allyene having 2 to 6 carbon atoms, A is a covalent bond of a group of the formula --B.sup.1 --N(R.sup.3)--, in which R.sup.3 has one of the meanings of R.sup.1 and B.sup.1 is an aliphatic or aromatic bridge member, and in which the group--N(R.sup.1) --B.sup.1 --N(R.sup.3)-- can also be in total a bivalent saturated heterocyclic radical, and Z.sup.0 is hydrogen or a group of the formula (4) ##STR3## in which A.sup.0 is a covalent bond or a radical or the formula --N(R.sup.4)--B.sup.2 -- having the meaning corresponding to the above formula --B.sup.1 (NR.sup.3)-- are described.

Abstract: Polyamine macrocyclic compounds, e.g. of 10 to 15 ring members and 3 to 6 ring amine nitrogens, linked through methylene groups to an aromatic moiety, show high selective activity against HIV.

Abstract: There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. The compounds are prepared by substitution of an amino-lactam with a substituted amide function. Growth promoting compositions containing such bezno-fused lactams as the active ingredient thereof are also disclosed.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle ribonic acid or a topically effective salt thereof, or ribonolactone.

Abstract: Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared by amidination or, depending on whether L is NH or O, by amide formation or esterification.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle ethyl pyruvate.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle isocitric acid or a topically effective salt thereof.

Abstract: The present invention provides dibenzoxazepine compounds of Formula I: ##STR1## which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.

Abstract: A novel compound and method for making and using compositions containing S--(--)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole hemihydrate useful for administration to a subject particularly for topical administration as a pharmaceutical agent for treating known conditions and disorder.

Abstract: Compounds of general formula (I) are useful for treating mental disorders, wherein R.sub.1 and R.sub.2 are the same or different and selected from hydrogen or lower alkyl; Ar are the same or different and selected from pyridyl and phenyl groups, n is 1 or 2, X is nitrogen or methine. When X is nitrogen, Y is methylene. When X is methine, Y is selected from nitrogen or oxygen. A is selected from carboxylic derivatives. The pharmacologically active salts of formula (I) are also embraced.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle gluconic acid or a topically effective salt thereof or gluconolactone.

Abstract: The invention comprises new compositions of matter, which are iron, manganese, cobalt or ruthenium complexes of porphyrins having hydrogen, haloalkyl or haloaryl groups in meso positions, two of the opposed meso atoms or groups being hydrogen or haloaryl, and two of the opposed meso atoms or groups being hydrogen or haloalkyl, but not all four of the meso atoms or groups being hydrogen. The invention also comprises new compositions of matter in which all four of the meso positions are substituted with haloalkyl groups and the beta positions are substituted with halogen atoms. A new method of synthesizing porphyrinogens is also provided.The novel compositions and others made according to the process of the invention are useful as hydrocarbon conversion catalysts; for example, for the oxidation of alkanes and the decomposition of hydroperoxides.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle saccharic acid or a topically effective salt thereof, or saccharolactone.

Abstract: Composition and method for enhancing therapeutic effects of topically applied agents are disclosed. The cosmetic or therapeutic composition may include one or more of cosmetic or pharmaceutical agents present in a total amount of from 0.01 to 40 percent and one or more of hydroxycarboxylic acids or related compounds present in a total amount of from 0.01 to 99 percent by weight of the total composition. The cosmetic and pharmaceutical agents may include but not limited to age spots, wrinkles and keratoses removing agents; vitamins; aloes; sun screens; tanning, depigmenting and shampooing agents; antiyeasts; antifungal, antibacterial and antiviral agents; topical bronchial dilators and topical cardiovascular agents; hormonal agents; vasodilators; retinoids and other dermatological agents. The hydroxycarboxylic acids and related compounds include organic alpha and beta hydroxycarboxylic acids, alpha and beta ketocarboxylic acids and salts thereof.

Abstract: A method for visibly reducing a facial wrinkle by topically applying to the wrinkle galactonic acid or a topically effective salt thereof, or galactonolactone.

Abstract: Triaza macrocycles carrying a -CH.sub.2 COOH, -CH.sub.2 CONR.sup.6 R.sup.7, --CH.sub.2 P(R.sup.5)O.sub.2 H, or --CH.sub.2 PO.sub.3 H.sub.2 group on two of the three ring nitrogen atoms and a --CH(L--Z)COOH, --CH(L--Z)CONR.sup.6 R.sup.7, --CH(L--Z)P(R.sup.5)O.sub.2 H, or --CH(L--Z)PO.sub.3 H.sub.2 group on the third ring nitrogen atom, in which L is an organic linking radical and Z is any group capable of reacting with a thiol, amino, carboxy, hydroxyl, aldehyde, aromatic, or heteroaromatic group, and metal complexes thereof, are useful for imaging, diagnosis, and therapy. A typical embodiment is N-[5-carboxy-5-{4,7-bis-(carboxymethyl)-1,4,7-triazacyclonon-1-yl}pentyl] 3-maleimidopropionamide.

Abstract: Triphendioxazine compounds of formula I, ##STR1## in which R.sub.1 and R.sub.2 are either both hydrogen or form a single chain linking the 8,9-; 9,10- or 10,11-positions, the single chain having the formula --NR.sub.5 ---(CO).sub.m --NH--, --CR.sub.5 .dbd.CH--CO--NH--, --CO--CH.sub.2 --CO--NH--, --CO--CH.dbd.CR.sub.5 --NH--, --CO--NH--CO--NH--, --CO--NH--CR.sub.6 .dbd.N--, --CR.sub.6 .dbd.N--CO--NH--, --NR.sub.5--(CO).sub.m --O--or --NH--CR.sub.5 .dbd.N--whereR.sub.5 is hydrogen, C.sub.1-4 alkyl or phenyl, R.sub.6 is hydrogen, C.sub.1-4 alkyl or phenyl;m is 1 or 2 and R.sub.3 and R.sub.4 are either both hydrogen or form a single chain linking the 1,2-, 2,3- or 3,4-positions, the single chain having a formula selected from --NR.sub.5 --(CO).sub.m --NH--, --CR.sub.5 .dbd.CH--CO--NH--, --O--CH.sub.2 --CO--NH--, --CO--CH.dbd.CR.sub.5 --NH--, --CO--NH--CO--NH--, --CONH--CR.sub.6 .dbd.N--, --CR.sub.6 .dbd.N--CO--NH--, --NR.sub.5 --(CO).sub.m --O--or --NH--CR.sub.5 .dbd.N--where the symbols R.sub.5, R.sub.

Abstract: This invention provides a novel series of substituted hexamethyleneimines which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.